Gill Livingston

Last updated
Gill Livingston
Alma mater University of Glasgow
OccupationPsychiatrist
Employer(s) University College London
Royal Free Hospital

Gill Livingston is a British psychiatrist awho is Professor of Psychiatry of Older People at University College London. Her research involves a life-course analysis of dementia risk and the development of strategies to delay or prevent dementia. She creates evidence-based interventions to improve the lives of people living with dementia and their families.

Contents

Early life and education

Livingston's grandmother emigrated from Eastern Europe to Scotland in the early 1900s. Her father was the first in her family to go to university. [1] Livingston studied medicine at the University of Glasgow. She specialised in psychiatry [2] after a placement in Friern Hospital. Livingston became interested in dementia during her work as clinical psychiatrist, where she observed the difference that family carers made to the prognosis of dementia patients. [1] This motivation to specialise in dementia strengthened after watching both her parents struggle with the condition; her father developed progressive supranuclear palsy and dementia in the 2000s and her mother in the 2010s. [1] Her first senior house officer position was at the Royal Free Hospital. [1]

Research and career

Livingston is an interdisciplinary researcher who combines psychiatry, epidemiological and biopsychosocial enquiry. She was made a professor of Old Age Psychiatry in 2007. [1] Her research investigates new modifiable risk factors for dementia risk, the impact of hearing impairments, and how to help the families of people living with dementia. [3] [4] She led The Lancet Commission on Dementia Prevention, Intervention and Care. [5] She combines new research with meta analysis to develop better understanding of dementia risk. [6] Her research has influenced UK and US policy on dementia risk, and revealed evidence-based interventions that could improve the lives of people with dementia.

Livingston pioneered the STrAtegies for RelaTives (START) programme, an 8 session intervention that helps the carers of people with dementia develop coping strategies. START increases the quality of life and reduces incidence of depression amongst the carers of people living with dementia. [4] She also launched the MARQUE project, a 5-year programme that looked to understand agitation, dementia and how to achieve culture change in care homes. [7] [8] In 2024 she reported that half of dementia cases could be prevented or delayed by addressing various risk factors, [9] [10] particularly high low-density lipoprotein (LDL) or "bad" cholesterol, social isolation and lower levels of education. [11] [12]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Preventive healthcare</span> Prevention of the occurrence of diseases

Preventive healthcare, or prophylaxis, is the application of healthcare measures to prevent diseases. Disease and disability are affected by environmental factors, genetic predisposition, disease agents, and lifestyle choices, and are dynamic processes that begin before individuals realize they are affected. Disease prevention relies on anticipatory actions that can be categorized as primal, primary, secondary, and tertiary prevention.

Derek Summerfield is an honorary senior lecturer at London's Institute of Psychiatry and a member of the Executive Committee of Transcultural Special Interest Group at the Royal College of Psychiatry. He is also an Honorary Fellow of the Egyptian Psychiatric Association. He has published around 150 papers and has made other contributions in medical and social sciences literature.

Viral pneumonia is a pneumonia caused by a virus. Pneumonia is an infection that causes inflammation in one or both of the lungs. The pulmonary alveoli fill with fluid or pus making it difficult to breathe. Pneumonia can be caused by bacteria, viruses, fungi or parasites. Viruses are the most common cause of pneumonia in children, while in adults bacteria are a more common cause.

The Global Burden of Disease Study (GBD) is a comprehensive regional and global research program of disease burden that assesses mortality and disability from major diseases, injuries, and risk factors. GBD is a collaboration of over 3600 researchers from 145 countries. Under principal investigator Christopher J.L. Murray, GBD is based in the Institute for Health Metrics and Evaluation (IHME) at the University of Washington and funded by the Bill and Melinda Gates Foundation.

The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory a web-based data knowledge and exchange platform, which will collate and disseminate key dementia data from members states. Although there is no cure for dementia, it is well established that modifiable risk factors influence both the likelihood of developing dementia and the age at which it is developed. Dementia can be prevented by reducing the risk factors for vascular disease such as diabetes, high blood pressure, obesity, smoking, physical inactivity and depression. A study concluded that more than a third of dementia cases are theoretically preventable. Among older adults both an unfavorable lifestyle and high genetic risk are independently associated with higher dementia risk. A favorable lifestyle is associated with a lower dementia risk, regardless of genetic risk. In 2020, a study identified 12 modifiable lifestyle factors, and the early treatment of acquired hearing loss was estimated as the most significant of these factors, potentially preventing up to 9% of dementia cases.

Frederick Wabwire-Mangen is a Ugandan physician, public health specialist and medical researcher. Currently he is Professor of Epidemiology and Head of Department of Epidemiology & Biostatistics at Makerere University School of Public Health. Wabwire-Mangen also serves as the Chairman of Council of Kampala International University and a founding member of Accordia Global Health Foundation’s Academic Alliance

<span class="mw-page-title-main">David Serwadda</span> Ugandan physician

David M. Serwadda is a Ugandan physician, medical researcher, academic, public health specialist and medical administrator. Currently he is a Professor of Public Health at Makerere University School of Public Health, one of the schools of Makerere University College of Health Sciences, a semi-autonomous constituent college of Makerere University, the oldest university in Uganda. Serwadda is also a founding member of Accordia Global Health Foundation's Academic Alliance.

<span class="mw-page-title-main">Margaret Mungherera</span> Ugandan physician

Margaret Mungherera was a senior consultant psychiatrist and medical administrator in Uganda. She served as the president of the Uganda Medical Association re-elected five times and ultimately the World Medical Association from October 2013 until October 2014. She advocated for psychiatric services throughout Uganda, beyond the capital, to improve conditions for Uganda's health-care providers and to get doctors organized in African countries in general.

<span class="mw-page-title-main">Clive Ballard</span> British researcher

Clive Ballard is a British, world-leading expert in dementia. He is currently Professor of Age-Related Diseases at the University of Exeter and Interim Deputy Pro-Vice-Chancellor and Dean of the University of Exeter Medical School.

<span class="mw-page-title-main">Joy Lawn</span>

Joy Elizabeth Lawn is a British paediatrician and professor of maternal, reproductive and child health. She is Director of the London School of Hygiene & Tropical Medicine Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre. She developed the epidemiological evidence for the worldwide policy and programming that looks to reduce neonatal deaths and stillbirths and works on large-scale implementation research.

<span class="mw-page-title-main">Miia Kivipelto</span> Finnish neurologist (born 1973)

Miia K. Kivipelto is a Finnish neuroscientist and professor at the University of Eastern Finland and Karolinska Institute in Stockholm. Her research focuses on dementia and Alzheimer's disease.

Kimberly A. Powers is an American epidemiologist who is an associate professor of epidemiology at the UNC Gillings School of Global Public Health. She combines epidemiology, statistics and mathematical modelling to understand the transmission of infectious diseases. In 2011 her work on antiretroviral therapy for the management of human immunodeficiency virus was selected by Science as the breakthrough of the year. During the COVID-19 pandemic, Powers looked to understand the spread of SARS-CoV-2.

<span class="mw-page-title-main">Elisabete Weiderpass</span> Brazilian cancer researcher

Elisabete Weiderpass-Vainio is a Brazilian cancer researcher who is Director of the International Agency for Research on Cancer, a part of the World Health Organization. Her research considers the epidemiology and prevention of cancer.

Paula Jean Clayton was an American psychiatrist. She was the first female chairperson of a major psychiatric department in the United States. She is known for destigmatising mental illness, rigorous data driven research methods to study psychiatry, especially depression and bipolar disorder.

<span class="mw-page-title-main">Lucy Chappell</span> British obstetrician and gynaecologist, researcher and chief executive officer

Lucy Chappell is a British professor of obstetrics at King’s College London and the Chief Scientific Adviser (CSA) for the UK Department of Health and Social Care. As part of her CSA role, she oversees the National Institute for Health and Care Research (NIHR) as Chief Executive Officer. Her research areas include medical problems during pregnancy such as pre-eclampsia, and the safety of medicines in pregnancy.

<span class="mw-page-title-main">Felicia Knaul</span> British-Canadian health economist (born 1966)

Felicia Marie Knaul is a British-Canadian health economist who is director of the University of Miami Institute for Advanced Study of the Americas and a professor at the Miller School of Medicine. She is an economist with the Mexican Health Foundation and president of the non-governmental organization Tómatelo a Pecho, an advocacy organisation that promote women's health in Latin America. Her research and leadership has focused around raising awareness of breast cancer in low and middle income countries.

Ashley Adamson is a British dietician, Professor of Public Health Nutrition at Newcastle University. She is director of the National Institute for Health and Care Research School for Public Health Research. Her research looks to understand the relationship between nutrient intake, food choices, socio-demographic characteristics and health outcomes. She was made a NIHR Senior Investigator in 2023.

<span class="mw-page-title-main">Rita Krishnamurthi</span> Epidemiologist in New Zealand

Rita V. Krishnamurthi is a New Zealand academic, and since 2023 is a full professor at the Auckland University of Technology, specialising in the epidemiology of stroke and dementia.

<span class="mw-page-title-main">Mina Fazel</span> British psychiatrist

Mina Fazel is a British psychiatrist who is Professor of Adolescent Psychiatry and Chair of the Department of Psychiatry at the University of Oxford. Her research considers the mental health of children and young people, and how to design effective mental health interventions.

Ruth Bonita, also known as Ruth Bonita Beaglehole, is an Australian–New Zealand academic, and is an emeritus professor at the University of Auckland, specialising in stroke. In 2006 she was appointed an Officer of the New Zealand Order of Merit for services to medicine. She is also an Honorary Doctor of Medicine at Umea University.

References

  1. 1 2 3 4 5 Davies, Rachael (December 2017). "Gill Livingston: transforming dementia prevention and care". The Lancet. 390 (10113): 2619. doi:10.1016/S0140-6736(17)31913-X.
  2. ↑ "Professor of Psychiatry of Older People". profiles.ucl.ac.uk. Retrieved 2024-08-04.
  3. ↑ "Livingston Gill".{{cite journal}}: Cite journal requires |journal= (help)
  4. 1 2 "Meet the expert: Professor Gill Livingston". Brain Sciences. 2022-02-18. Retrieved 2024-08-04.
  5. ↑ Livingston, Gill; Sommerlad, Andrew; Orgeta, Vasiliki; Costafreda, Sergi G; Huntley, Jonathan; Ames, David; Ballard, Clive; Banerjee, Sube; Burns, Alistair; Cohen-Mansfield, Jiska; Cooper, Claudia; Fox, Nick; Gitlin, Laura N; Howard, Robert; Kales, Helen C (December 2017). "Dementia prevention, intervention, and care". The Lancet. 390 (10113): 2673–2734. doi:10.1016/S0140-6736(17)31363-6. hdl: 10026.1/18238 .
  6. ↑ "Professor Gill Livingston". ARC North Thames. Retrieved 2024-08-04.
  7. ↑ "Project streams: Information and Updates". Psychiatry. 2019-02-04. Retrieved 2024-08-04.
  8. ↑ "livingston-g". Psychiatry. 2019-02-04. Retrieved 2024-08-04.
  9. ↑ Livingston, Gill; Huntley, Jonathan; Liu, Kathy Y; Costafreda, Sergi G; Selbæk, Geir; Alladi, Suvarna; Ames, David; Banerjee, Sube; Burns, Alistair; Brayne, Carol; Fox, Nick C; Ferri, Cleusa P; Gitlin, Laura N; Howard, Robert; Kales, Helen C (July 2024). "Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission". The Lancet. doi:10.1016/s0140-6736(24)01296-0. ISSN   0140-6736.
  10. ↑ "Two new dementia risks identified by major report". BBC News. 2024-07-31. Retrieved 2024-08-04.
  11. ↑ "Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors". UCL News. 2024-07-31. Retrieved 2024-08-04.
  12. ↑ Gregory, Andrew (2024-07-31). "Almost half of dementia cases could be prevented or delayed, study finds". The Guardian. ISSN   0261-3077 . Retrieved 2024-08-04.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.